2 Of King's Skelaxin Patents Invalidated
A federal judge has invalidated two of King Pharmaceuticals Inc.'s patents that cover the muscle relaxant Skelaxin, although the company still has one patent for the drug not affected by the...To view the full article, register now.
Already a subscriber? Click here to view full article